| Merck (Schweiz) AG - Erbitux 500 mg/100 ml, Infusionslösung |
| 56072 | | 03 | | Erbitux 500 mg/100 ml | | Infusionslösung | | L01FE01 | | Cetuximab | | 15.09.2014 | | |
|
| Composition |
| cetuximabum 500 mg, natrii chloridum, glycinum, polysorbatum 80, acidum citricum monohydricum, natrii hydroxidi solutio 1 mol/L, aqua ad iniectabile q.s. ad solutionem pro 100 ml natrium 288 mg. |
| Packungsbestandteile |
| Infusion solution | | | | | | | | Active Agent | Dose |
|---|
| Cetuximab | 500mg / 100ml |
| | BAG: Active Agent | Dose |
|---|
| Cetuximab | 500 mg |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Glycin | | | Mol/l | | | Sodium Chloride | | | Natrii Hydroxidi Solutio | 1 | | Polysorbatum 80 | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 100 ml | 937.18 | 1035.65 | A | SL | No |
|
